...
首页> 外文期刊>Angiology: the Journal of Vascular Diseases >Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve' Implantation
【24h】

Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve' Implantation

机译:经皮麦粉的外科治疗,以最大限度地减少经齿轮主动脉瓣有关的血管并发症“植入

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Transcatheter aortic valve implantation (TAVI) is associated with substantial rates of vascular complications. The aim of our study is to describe the surgical management of percutaneous transfemoral access by a vascular surgeon and to report the 30-day postoperative vascular complications and mortality. Perioperative procedures to manage the femoral access site were recorded retrospectively from 220 consecutive patients who underwent TAVI. Postoperative vascular complications related to the main access were categorized according to the Valve Academic Research Consortium 2 classification. Perioperative procedures related to vascular access were performed for 56 (25.4%) patients: 6 patients required open surgical repair, 48 patients underwent endovascular stenting, and 2 patients had both procedures. The all-cause mortality was 3.6%, but no death related to a vascular complication was reported during the 30-day postoperative follow-up period. Ten (4.5%) patients developed postoperative hematomas; 2 (0.9%) of them were retroperitoneal and led to major bleeding requiring an unplanned surgical intervention. Our study underlines the utility of a multidisciplinary approach to manage the percutaneous access in TAVI for managing postoperative vascular complications.
机译:经导管主动脉瓣植入(Tavi)与血管并发症的大量相关。我们的研究目的是描述血管外科医生经皮犯规进入的手术管理,并报告30天的术后血管并发症和死亡率。管理股骨头接入站点的围手术期程序从接受TAVI的220名连续患者中记录了股息。根据阀门学术研究联盟2分类,分类了与主要访问相关的术后血管并发症。围手术期与血管进入相关的程序进行56例(25.4%)患者:6名患者需要开放的手术修复,48名患者接受过血管内支架,2名患者有两种程序。全因死亡率为3.6%,但在30天的术后随访期间报告了与血管并发症有关的死亡。十(4.5%)术后血肿患者; 2(0.9%)它们是腹膜后的,导致需要计划生意外的手术干预的重大出血。我们的研究强调了多学科方法来管理Tavi的经皮访问,以管理术后血管并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号